200
Participants
Start Date
September 1, 2022
Primary Completion Date
December 31, 2042
Study Completion Date
December 31, 2042
Annual surveillance
Annual surveillance includes annual MRI and/or an assessment new onset diabetes and unintended weight loss.
Oslo University Hospital, Oslo
Collaborators (1)
Helse Sor-Ost
OTHER_GOV
University of Oslo
OTHER
Haukeland University Hospital
OTHER
St. Olavs Hospital
OTHER
Helse Stavanger HF
OTHER_GOV
University of Bergen
OTHER
Immunovia, Inc.
INDUSTRY
University Hospital of North Norway
OTHER
Oslo University Hospital
OTHER